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Abstract  
Introduction: Hemiplegia is one of the most common paralysis these last years. The risk factors of 
this pathology are thrombosis, arterial hypertension, diabetes, stress, and so on. This illness has 
serious consequences for the patient and isolates him/her from many family and social activities. Early 
rehabilitation by physiotherapist is very important for a greater recovery of lost functions.  
Objective: The main purpose of this study is to confirm the efficacy of TENS in hemiplegic patients to 
reduce spasticity and to restore lost reflexes.  
Methodology: The patients taken to this study were with Hemiplegia caused by cerebrovascular 
accidents. The study included 32 patients of whom 22 were females and 10 were males. Patients 
referred loss of sensitivity and motor movement of the foot and hand and an increased spasticity. The 
study was based on two methods: TENS treatment and placebo stimulation.  
Results: After 9 months of study, in different periods and groups of patients, it was observed that 
patients who used TENS had decreased spasticity, improved  plantar and dorsal flexion and delayed 
stretch reflexes compared to patients who used placebo stimulation and hadn’t significant effects. 
Conclusion: Depending on all the studies we concluded that patients who used TENS on their 
treatment had satisfactory improvements and returned to normal life activities. 
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Introduction 
Hemiplegia is defined as the loss of volunteer movement with muscle tone and 
sensitivity irritation in the entire left or right side of the body. Etiology Cerebro-vascular 
diseases are one of the main causes of Hemiplegia. Other causes are: cranioencephalic 
traumas, cerebral tumors, infections, cerebral arthritis and multiple sclerosis. 
The clinic and progressive course  
The progressive course is divided into three stages. The first stage is sleeping period. It 
usually occurs in coma processes due to haemorrhage. The second stage is Flaccid 
Hemiplegia. It is associated with the absence of cerebral control where all of reflexes 
disappear. This period takes 4-5 weeks, and then appears Hypertonia. The third stage 
is Spastic Hemiplegia where the inferior centers begin to recover and the reflexes 
appear. The tone grows and spasticity appears.  After the acute phase it is noticed that 
the lower limb starts to recover faster than the upper limb. Within three months, the 
patient begins to walk, but the hand will stay for a long time compromised. Five 
International Journal of Medicine & Healthcare 
Vol. 2, No. 2, 2017, pp. 1-7 
www.ijmh.ielas.org                                                                                                                                               
ISSN: 2545-4188 (Online) 
 
2 
 
problems that accompany Hemiplegia are muscle tone changes, sensitive changes, loss 
of motor movement, loss of balance reactions, and communication.  
The posture and the movement of hemiplegic patient  
The patient benefits if the elements he is interested in are on the damaged side. The 
television, remote control, water cups should be placed on the damaged side to 
stimulate patient moves this part of body. The bed should have a strong mattress that 
can be adjusted. The patient should change the position every two hours to prevent 
decubitus wounds or pressure sores.  
Stages of hemiplegic patient treatment 
The treatment should start immediately after the stabilization of Hemiplegia. The 
prognosis will be faster if the patient is treated twice or three times a day in the early 
stages. 
TENS Transcutaneous electrical nerve stimulation (TENS or TNS) is the use of electric 
current produced by a device to stimulate the nerves for therapeutic purposes. TENS, 
by definition, covers the complete range of transcutaneously applied currents used for 
nerve excitation although the term is often used with a more restrictive intent, namely 
to describe the kind of pulses produced by portable stimulators used to treat pain.  
The unit is usually connected to the skin using two or more electrodes mostly auto 
adhesive electrodes to reduce the risk of skin infection and for easier application. A 
typical battery-operated TENS unit is able to modulate pulse width, frequency and 
intensity. Generally TENS is applied at high frequency (>50 Hz) with an intensity below 
motor contraction (sensory intensity) or low frequency (<10 Hz) with an intensity that 
produces motor contraction. The success is not guaranteed with the application of 
TENS. The percentage of patients profiting pain reduction is 65% for acute pain and 
50% for chronic pain. The typical current intensity is 0-80 mA.  
Mechanism of action  
The type of stimulation offered by TENS tends to activate the natural specific 
mechanisms of pain reduction: the gate control mechanism of pain and the opioid 
system. Reducing pain through the gate control mechanism involves the activation of 
A-beta sensors that reduce the transmission of nociceptive stimulus from the 'C' fibers 
through the spinal column. The stimulation should be with high frequencies (90-130Hz). 
Another way is to stimulate A-delta fibers with low intensity (2-50Hz) which will 
activate opioid mechanisms and provide pain reduction by releasing an endogenous 
opioid (Encephaline) in the spinal cord that will reduce activation of toxins in sensitive 
paths. The third possibility is to stimulate simultaneously two fiber nerves through the 
Burst Model, which gives a slower effect and which lasts longer.  
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Application of TENS in clinical practice 
There is currently a general consensus that favors the application of TENS in different 
clinical situations. The time from the beginning of the treatment to the analgesic period 
varies from immediate effect to several hours (20 -30 minutes) in 75% of patients and 
1 hour to 95% of patients. The duration of the analgesic effect depends on the time of 
application and pain intensity.  
Effects of TENS  
TENS is effective to treat acute and chronic pain. It decreases drug dependence and 
pain tolerance, and also it helps in physiological factors and post operative situations.  
TENS’ program names 
Traditional TENS uses high frequency stimulation 90-130Hz applied for 30min. 
Acupuncture TENS uses frequency stimulation 2 to 5Hz applied for 30min. The effect is 
achieved slowly but lasts longer. Intensive brief TENS is used to achieve rapid pain 
relief but some patients cannot support the power of stimulation. The frequency and 
intensity of stimulation is different for each patient.  
Methods and Materials 
There are 32 patients taken in the study. All of these patients suffer from spastic 
hemiparesis caused by cerebrovascular accidents. Patients taken in the study are 
selected by these criteria: 
- Lower limbs spasticity 
- A passive dorsal flexion of ankle less than 10 grades 
- Without prior history of neurological disorders 
- Without major damage and pain to the lower limbs 
 
Patients were advised and informed about the nature of the study and have given their 
approval.  
 
Clinical evaluation 
 
The clinical examinations evaluate the spasticity of Achilles tendon, the resistance of 
the passive dorsal flexion of ankle and the duration and the amount of ankle spasms. 
This assessment was conducted by the same examiner using a four-point scale for 
repeated spasms and a five-point scale for the two other types. While the points for the 
"Passive dorsal flexion resistance" phenomenon was doubled. These amounts of points 
were collected to generate total spasticity scores. The points in the range from 0 to 9 
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correspond to the lightest form of spasticity, from 10 to 12 correspond to the moderate 
form and from 13 to 16 correspond to severe spasticity. Initially, subjects were 
randomly distributed, 25 patients treated with TENS and 7 patients with placebo 
stimuli. As the placebo stimulation did not have much effect, these patients underwent 
in TENS therapy for 3 weeks increasing the number of patients treated with TENS. 
 
Table 1 A comparison between clinical data of spastic hemiparetic patient with TENS and Placebo treatment 
Clinical data Reflexes’ profile Maximal contractions 
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The group with TENS stimulation               
75 L.CVA 18 6 17.1 53.4 7 37 16.1 5 
49 L.CVA 27 9 98.1 17 16.9 82 16.7 7.3 
67 L.CVAᵇ 8 9 22.3 80.9 29.5 27 10.7 4.2 
31 L.CVA 25 10 94.7 43.2 20.3 53 22.4 5.8 
76 R.CVAᵇ 43 10 19.8 81.7 11.5 29 10.4 7.9 
43 L.CVA 8 11 19.9 24.3 12.1 16 28.9 1.4 
67 R.CVA 23 12 88.6 29.8 23.2 51 23.8 6.4 
57 L.CVA 85 13 100 96.3 13.5 60 3.1 0 
73 R.CVAᵇ 26 13 57.9 30.12 11.4 100 12.4 0 
58 R.CVA 16 15 77.9 96.3 11.4 48 10.5 1.2 
47 L.CVAᵇ 11 16 100 81.4 10.5 100 17.6 0 
58.5 
 
26.4 11.2 63.3 57.7 15.2 50.3 15.7 3.6 
14.7 
 
21.9 2.9 36.6 30.3 6.6 25.7 7.3 3.1. 
  
        
  
The group with placebo treatment 
      
  
67 L.CVAᵇ 8 9 22.3 80.9 29.5 37 11 3.1 
76 R.CVAᵇ 43 10 19.8 81.7 11.5 65 12.3 0 
58 L.CVA 50 12 85.9 76.9 8.2 49 9.5 1 
47 R.CVA 37 13 60.2 75.6 10.6 53 13.5 5.1 
73 R.CVAᵇ 26 13 57.9 30.1 11.4 100 9 5 
47 L.CVAᵇ 11 16 100 84.3 10.5 100 14 0 
64.7 
 
29.2 11.8 57.7 71.6 13.6 68 11.6 2.4 
10.6 
 
17.2 2.5 32.5 20.6 7.9 27.8 2.1 2.4 
                    
 
Spasticity points: 0-9 lightest form; 10-12 moderate form; 13-16 severe form -10 patients took part at both groups 
SR=Stretch Reflex, PF/DF=plantar flexion/dorsal flexion, L/R CVA = Left/Right, CVA- Cerebro-vascular accidents 
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Instrumental protocol  
 
Most subjects were tested twice a week to determine the reproducibility of the data. 
The test consists in 5 measurements: 
-Clinical spasticity points 
-The maximal amplitude of H reflex as a percentage of maximal response M (H / M) 
-The amount of H reflex inhibited during vibration 
-The excitability of stretch reflex 
-Volunteer isometric plantar and dorsal flexion of ankle  
 
The test procedure is performed as follows: The spasticity of ankle joint was the first 
evaluation. The main threshold of sensitivity was defined as the average after three 
tests in which the stimulation intensity gradually increased from the moment when 
patients referred nerve tickle. The subjects were informed that they might not feel 
anything by stimulation. Under these conditions, the undergrowth was considered 
placebo stimulation for 60 minutes, days/weeks. This time of treatment was considered 
optimal based on the previous findings of the effects of a single electrical stimulation in 
pain. To reduce the time course and stimulation effects in the five factors taken in the 
study, the measurements were repeated after 2-3 weeks from the stimulation.  
 
The results  
 
Based on the clinical evaluations of the subjects, 8 of them had light spasticity, 12 
moderate spasticity and 5 severe spasticity. In the placebo group, 5 had light spasticity 
and 2 other had severe spasticity. The effects of TENS and placebo stimulation on 
spasticity and H reflex’s points. After all the tests, it was noted a significant reduction of 
hemiparetic spasticity after 2 weeks of treatment and the additional week did not 
produce further reductions. The effects of TENS and placebo stimulation on stretch 
reflex. After all the observations, it was noted that the TENS treatment but not placebo 
stimulation tended to delay and to reduce the magnitude of stretch reflexes. Specifically 
after 3 weeks, stretch reflex was extended to 134.6 ± 69.7% compared with placebo 
stimulation 105.9 ± 31.9%. The effects of TENS and placebo stimulation in maximal 
isometric volunteer contractions. The most impressive result of our study was the 
improvement of dorsal flexion in the affected limb. 15 patients had a maximum control 
force of 1.4 kg before TENS treatment and after two weeks it was increased by 3.4 kg. 
At the end of the 3rd week treatment it was 7.4 kg. The range of this clinical 
improvement varied from 5% to 80% in 20 subjects. However, the plantar flexion force 
showed only a slight increase from both therapies TENS and Placebo without significant 
differences between the values of the two groups. The relief of hemiparetic spasticity 
from TENS. The EMG contraction rates during dorsal and plantar flexion were stable 
throughout days. The group  that received TENS treatment, the contraction rate before 
the treatment  was 50 ± 21.4%, during the treatment was 42±16.5% and after it was 
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38.1±24% (respectively after two and three weeks of treatment). During plantar 
flexion, the rate of contraction remained stable for two weeks after stimulation 
49.2±32.8% and significantly decreased to 32.1±18% at the end of the third week.  
Placebo stimulation there had no effect on the two types contraction.  
 
Discussion  
 
Our main findings from this study demonstrate that repeatedly applications of TENS 
significantly improve clinical spasticity simultaneously with volunteer motor reflexes in 
hemiparetic patients. Specifically, TENS therapy:                                                                                                                                              
 reduced spasticity scores       
 increased the vibrant inhibition of H reflexes  
 reduced the magnitude of stretch reflexes of the soleus muscle   
 improved the force of dorsal flexion    
 reduced the EMG at the co-contraction rates.  
 
Conclusion 
 
The results of the study showed initial improvements of dorsal flexion and after 2 weeks 
of TENS stimulation we noted partial improvement as a result of H reflex inhibitors. 
These changes were accompanied by a reduction of stretch reflex magnitude in plantar 
flexion and co-contraction of EMG scales only after three weeks of stimulation. Another 
factor in this study was the vibratory growth of H reflex inhibition through repeated 
TENS application. This may have been due to a reinforcement of presynaptic inhibition 
that has been proven to be inhibited in spastic Hemiplegia (Ashlay and Verrier, 1976). 
It was interesting that TENS treatment resulted in a pronounced increase in dorsal 
flexion but not of plantar flexion. As it can be partially mentioned at the introductory 
part of our study, at least two current mechanisms can affect voluntary spasticity 
abnormalities. On the one hand, the lower threshold of stretch reflexes can result as an 
excitement of hyperactive segmental reflexes whereas on the other hand, we may 
assume that part of motor deficit in the poorly dorsal flexion is associated with the 
deficiency or the decreasing of the excitability of flexor motor neurons. Repeated TENS 
stimulation may have improved dorsal flexor by increasing the inhibition of presynaptic 
associated with a hyper excitability of stretch plantar flexion and by reducing EMG 
contraction rate. 
 
International Journal of Medicine & Healthcare 
Vol. 2, No. 2, 2017, pp. 1-7 
www.ijmh.ielas.org                                                                                                                                               
ISSN: 2545-4188 (Online) 
 
7 
 
References  
1. Levin MF, Hui-Chan CWY. Relief of hemiparetic spasticity by TENS is associated with 
improvement in reflex and voluntary motor functions. Electroencephalogr Clin 
Neurophysiol. 1992; 85:131–142.  
2. Almay, B.G.L., Johansson, F., Von Knorring, L., Sakurada, T., Terenius, L. Long-term 
high frequency transcutaneous electrical nerve stimulation (hi-TENS) in chronic pain. 
Clinical response and effects of CSF-endorphins, monoamine metabolites, substance 
P-like immunoreactivity (SPLI) and pain measures. Psychosom. Res. 1985; 29:247–
257. 
3. Hale, J.L., Chan, C.W.Y. Possible enhancement of presynaptic inhibitory mechanisms 
following nine days of TENS in hemiplegic patients. In: Proc. Int. Union Physiol. Sci. 
XVI.; 1986:256. 
4. Wikipedia: TENS 
5. Wikipedia: Hemiplegia 
6. E. Hiluk. Neurological rehabilitation 
7. Ali Aliu, Visar Memaj: Modalitetet Termale 
 
